Dizziness or lightheadedness
In clinical trials, retatrutide users shed 22 to 29 percent of their body weight
Thigh: Choose a different area of your thigh each time
Moreover, efpeglenatide therapy reduced the risk of CV disease by about 27% compared to the placebo in the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) study [51]
However, mood symptoms may return if weight is regained, if previous coping patterns reemerge, or if individuals find that weight loss alone does not resolve underlying issues related to relationships, self-esteem, or other psychosocial concerns
How GLP-1 Drugs Promote Weight Loss Signals a feeling of being full Slows down digestion Regulates the release of insulin from the pancreas Who Is Eligible to Use GLP-1 Drugs for Weight Loss